{"transactions":[{"id":747785,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:35:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259742","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259742/ownership.xml","form_type":"4"}},{"id":1117768,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:06.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083693/ownership.xml","form_type":"4"}},{"id":1497759,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:10:03.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066584/ownership.xml","form_type":"4"}},{"id":1874682,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T20:15:14.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2024 and (2) the date of the Issuer's 2024 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":0.972,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-032867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123032867/doc4.xml","form_type":"4"}},{"id":2253231,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T20:29:06.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2023 and (2) the date of the Issuer's 2023 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":1.69,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-032555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919122032555/doc4.xml","form_type":"4"}},{"id":2413372,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T18:07:58.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests over a four-year period at the rate of 25% on 01/04/2023 and then in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":7.8,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-22-001085","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218022001085/primarydocument.xml","form_type":"4"}},{"id":2413371,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T18:07:58.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2023, 25% on 01/04/2024, 25% on 01/04/2025, and 25% on 01/04/2026."}],"balance_after":125385,"source":{"system":"sec-edgar","filing":"0001562180-22-001085","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218022001085/primarydocument.xml","form_type":"4"}},{"id":2510361,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-16T06:29:04.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":170655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on September 1, 2021 and vests over a four-year period at the rate of 25% on August 2, 2022 and then in 36 equal monthly installments thereafter. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on September 1, 2021 and vests over a four-year period at the rate of 25% on August 2, 2022 and then in 36 equal monthly installments thereafter. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on September 1, 2021 and vests over a four-year period at the rate of 25% on August 2, 2022 and then in 36 equal monthly installments thereafter. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":170655,"derivative":{"exercise_price":9.13,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":170655},"source":{"system":"sec-edgar","filing":"0001628280-21-023462","document":"wf-form4_163706207928299.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023462/wf-form4_163706207928299.xml","form_type":"4"}},{"id":2510360,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-16T06:29:04.000Z","date":"2021-11-11","kind":"other","acquired":true,"shares":100385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units awarded to the reporting person prior to the separation (the \"Separation\") of 2seventy bio, Inc. (\"2seventy\") from bluebird bio, Inc. (\"bluebird\"). In connection with the Separation, the restricted stock units underlying this award were adjusted pursuant to the Employee Matters Agreement by and between 2seventy and bluebird (the \"EMA\") to preserve the value associated with the original restricted stock unit award (see footnotes 2 and 3). This restricted stock unit award was originally granted on September 1, 2021 and vests over a four-year period at the rate of 25% on August 2, 2022, 25% on August 2, 2023, 25% on August 2, 2024 and 25% on August 2, 2025."},{"field":"security","element":"securityTitle","label":"F2","text":"bluebird equity awards granted prior to January 1, 2021 were converted into equity awards of both bluebird and 2seventy. The number of shares underlying the converted bluebird equity awards was determined by multiplying the number of shares underlying the existing bluebird equity award by a fraction, the numerator of which is the volume-weighted average trading price of bluebird common stock (trading \"regular way\") on the five trading days immediately prior to the distribution date (the \"bluebird Pre-Distribution VWAP\") and the denominator of which is the sum of (1) the volume-weighted average trading price of 2seventy common stock (trading \"regular way\") on the five trading days immediately following the distribution date multiplied by the distribution ratio and (2) the volume-weighted average trading price of bluebird bio common stock (trading \"regular way\") on the five trading days immediately following the distribution date (the \"bluebird Post-Distribution VWAP\")."},{"field":"security","element":"securityTitle","label":"F3","text":"bluebird equity awards granted on or after January 1, 2021, such equity awards continued as bluebird equity awards, subject to adjustment. The adjusted number of shares of bluebird common stock underlying such equity awards is equal to the number of shares of bluebird common stock subject to the equity award immediately prior to the distribution multiplied by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the bluebird Post-Distribution VWAP."}],"balance_after":100385,"source":{"system":"sec-edgar","filing":"0001628280-21-023462","document":"wf-form4_163706207928299.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023462/wf-form4_163706207928299.xml","form_type":"4"}},{"id":2649488,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-30T17:59:23.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in twelve equal month installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) beginning on the on the last day of each month over a period from June, 2021 to May, 2022, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":4.16,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-087402","document":"tm2121071-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526119/000110465921087402/tm2121071-4_4seq1.xml","form_type":"4"}},{"id":2698715,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T20:56:13.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 20, 2022 and (2) the date of the Issuer's 2022 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":4.03,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-035371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919121035371/doc4.xml","form_type":"4"}},{"id":2767924,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2021-03-30T21:06:12.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":56372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock units, granted as a retention award, vest as to 50% of the shares of Class A Common Stock on each of May 19, 2022 and May 18, 2023."}],"balance_after":392616,"source":{"system":"sec-edgar","filing":"0001209191-21-023572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121023572/doc4.xml","form_type":"4"}},{"id":2819846,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:34:50.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":6980,"price":9.11,"value":63587.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020."}],"balance_after":336244,"source":{"system":"sec-edgar","filing":"0001209191-21-016018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121016018/doc4.xml","form_type":"4"}},{"id":2819845,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:34:50.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":6242,"price":9.11,"value":56864.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019."}],"balance_after":343224,"source":{"system":"sec-edgar","filing":"0001209191-21-016018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121016018/doc4.xml","form_type":"4"}},{"id":2819844,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:34:50.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":2527,"price":9.11,"value":23020.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018."}],"balance_after":349466,"source":{"system":"sec-edgar","filing":"0001209191-21-016018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121016018/doc4.xml","form_type":"4"}},{"id":2819843,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:34:50.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":2657,"price":9.11,"value":24205.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017."}],"balance_after":351993,"source":{"system":"sec-edgar","filing":"0001209191-21-016018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121016018/doc4.xml","form_type":"4"}},{"id":2835740,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2021-02-24T21:02:01.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":84951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":354650,"source":{"system":"sec-edgar","filing":"0001209191-21-013741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121013741/doc4.xml","form_type":"4"}},{"id":2986408,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2020-11-10T21:03:50.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":590,"price":10.92,"value":6442.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 2, 2018."}],"balance_after":269699,"source":{"system":"sec-edgar","filing":"0001209191-20-057600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120057600/doc4.xml","form_type":"4"}},{"id":2986407,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2020-11-10T21:03:50.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":825,"price":10.92,"value":9009.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016."}],"balance_after":270289,"source":{"system":"sec-edgar","filing":"0001209191-20-057600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120057600/doc4.xml","form_type":"4"}},{"id":3002054,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-21T21:32:32.000Z","date":"2020-10-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest in three approximately equal installments, assuming continuous service on each vesting date, as follows: October 19, 2021; October 19, 2022; and October 19, 2023."}],"balance_after":20000,"derivative":{"exercise_price":15.55,"expiration_date":"2030-10-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-055491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120055491/doc4.xml","form_type":"4"}},{"id":3105109,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T21:27:23.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":35342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which the remaining unvested portion shall vest), beginning on June 30, 2020 and ending on May 31, 2021, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":35342,"derivative":{"exercise_price":1.77,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":35342},"source":{"system":"sec-edgar","filing":"0000904454-20-000402","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526119/000090445420000402/edgar.xml","form_type":"4"}},{"id":3238003,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2020-03-02T21:01:51.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":68327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to approximately 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":271114,"source":{"system":"sec-edgar","filing":"0001209191-20-014402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120014402/doc4.xml","form_type":"4"}},{"id":3249150,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2020-02-25T21:31:54.000Z","date":"2020-02-21","kind":"sale","acquired":false,"shares":6181,"price":11.63,"value":71885.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.58 to $11.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":202787,"source":{"system":"sec-edgar","filing":"0001209191-20-012474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/doc4.xml","form_type":"4"}},{"id":3249149,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2020-02-25T21:31:54.000Z","date":"2020-02-21","kind":"sale","acquired":false,"shares":2558,"price":11.63,"value":29749.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.58 to $11.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":208968,"source":{"system":"sec-edgar","filing":"0001209191-20-012474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/doc4.xml","form_type":"4"}},{"id":3249148,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2020-02-25T21:31:54.000Z","date":"2020-02-21","kind":"sale","acquired":false,"shares":2252,"price":11.63,"value":26190.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.58 to $11.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":211526,"source":{"system":"sec-edgar","filing":"0001209191-20-012474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/doc4.xml","form_type":"4"}},{"id":3249147,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2020-02-25T21:31:54.000Z","date":"2020-02-21","kind":"sale","acquired":false,"shares":1510,"price":11.63,"value":17561.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.58 to $11.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":213778,"source":{"system":"sec-edgar","filing":"0001209191-20-012474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/doc4.xml","form_type":"4"}},{"id":3336758,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2019-12-18T21:33:26.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":41150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock units, granted as a special retention award, vest as to 100% of the shares of Class A Common Stock on November 18, 2021."}],"balance_after":215288,"source":{"system":"sec-edgar","filing":"0001209191-19-061129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119061129/doc4.xml","form_type":"4"}},{"id":3374412,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2019-11-12T23:23:03.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":630,"price":11,"value":6930.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 2, 2018."}],"balance_after":174138,"source":{"system":"sec-edgar","filing":"0001209191-19-056188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/doc4.xml","form_type":"4"}},{"id":3374411,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2019-11-12T23:23:03.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":880,"price":11,"value":9680.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016."}],"balance_after":174768,"source":{"system":"sec-edgar","filing":"0001209191-19-056188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/doc4.xml","form_type":"4"}},{"id":3433128,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2019-08-20T21:37:46.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":212,"price":9.04,"value":1916.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 16, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.94 to $9.13, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":175648,"source":{"system":"sec-edgar","filing":"0001209191-19-046846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119046846/doc4.xml","form_type":"4"}},{"id":3478542,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-26T01:50:07.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":5137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which the remaining unvested portion shall vest), beginning on 7/21/2019 and ending on 06/21/2020, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":5137,"derivative":{"exercise_price":1.81,"expiration_date":"2029-06-21","underlying":"Common Stock","underlying_shares":5137},"source":{"system":"sec-edgar","filing":"0001104659-19-037505","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526119/000110465919037505/a4.xml","form_type":"4"}},{"id":3527568,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2019-05-14T20:08:28.000Z","date":"2019-05-10","kind":"sale","acquired":false,"shares":4055,"price":10.53,"value":42699.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on July 31, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.71, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":175860,"source":{"system":"sec-edgar","filing":"0001209191-19-029596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119029596/doc4.xml","form_type":"4"}},{"id":3564594,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:11:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":16804,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2019."}],"balance_after":161804,"derivative":{"exercise_price":11.49,"expiration_date":"2029-01-29","underlying":"Class A Common Stock","underlying_shares":16804},"source":{"system":"sec-edgar","filing":"0001209191-19-023430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/doc4.xml","form_type":"4"}},{"id":3564593,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:11:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":5099,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2018."}],"balance_after":65099,"derivative":{"exercise_price":12.95,"expiration_date":"2028-02-21","underlying":"Class A Common Stock","underlying_shares":5099},"source":{"system":"sec-edgar","filing":"0001209191-19-023430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/doc4.xml","form_type":"4"}},{"id":3564592,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:11:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":1236,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, granted as a promotion award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of November 27, 2017."}],"balance_after":16236,"derivative":{"exercise_price":13.6,"expiration_date":"2028-01-02","underlying":"Class A Common Stock","underlying_shares":1236},"source":{"system":"sec-edgar","filing":"0001209191-19-023430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/doc4.xml","form_type":"4"}},{"id":3564591,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:11:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":695,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2016."}],"balance_after":30695,"derivative":{"exercise_price":9.12,"expiration_date":"2026-03-01","underlying":"Class A Common Stock","underlying_shares":695},"source":{"system":"sec-edgar","filing":"0001209191-19-023430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/doc4.xml","form_type":"4"}},{"id":3564590,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:11:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":77,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of September 16, 2015."}],"balance_after":5077,"derivative":{"exercise_price":10.2,"expiration_date":"2025-09-16","underlying":"Class A Common Stock","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001209191-19-023430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/doc4.xml","form_type":"4"}},{"id":3564589,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:11:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":3563,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, granted as a new hire award, is presently exercisable in full."}],"balance_after":43563,"derivative":{"exercise_price":13.78,"expiration_date":"2024-07-01","underlying":"Class A Common Stock","underlying_shares":3563},"source":{"system":"sec-edgar","filing":"0001209191-19-023430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/doc4.xml","form_type":"4"}},{"id":3564588,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Class A Common Stock","published_at":"2019-04-03T22:11:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":16731,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\"), the reporting person received 16,731 restricted stock units as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation.  The restricted stock units are subject to vesting conditions consistent with the terms of the existing Ironwood restricted stock units held by the reporting person prior to the Separation."}],"balance_after":179915,"source":{"system":"sec-edgar","filing":"0001209191-19-023430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/doc4.xml","form_type":"4"}},{"id":3638641,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":18,"price":14.32,"value":257.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.24 to $14.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":163184,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3638640,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":17,"price":14.32,"value":243.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.24 to $14.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":163202,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3638639,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":9,"price":14.32,"value":128.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.24 to $14.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":163219,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3638638,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":2,"price":14.32,"value":28.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.24 to $14.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":163228,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3638637,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":2237,"price":14.31,"value":32011.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.12 to $14.59, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":163230,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3638636,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":1957,"price":14.31,"value":28004.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.12 to $14.59, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":165467,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3638635,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":1119,"price":14.31,"value":16012.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.12 to $14.59, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":167424,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3638634,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-02-22T21:47:11.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":318,"price":14.31,"value":4550.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.12 to $14.59, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":168543,"source":{"system":"sec-edgar","filing":"0001209191-19-012630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119012630/doc4.xml","form_type":"4"}},{"id":3681231,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option(Right to Buy)","published_at":"2019-01-31T22:32:04.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2019."}],"balance_after":145000,"derivative":{"exercise_price":12.9,"expiration_date":"2029-01-29","underlying":"Class A Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001209191-19-006220","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119006220/doc4.xml","form_type":"4"}},{"id":3681230,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-31T22:32:04.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":72500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":168861,"source":{"system":"sec-edgar","filing":"0001209191-19-006220","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119006220/doc4.xml","form_type":"4"}},{"id":3766812,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-11-14T02:41:15.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":1358,"price":11.81,"value":16037.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on each of December 16, 2016 and January 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.64 to $12.03, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":96361,"source":{"system":"sec-edgar","filing":"0001209191-18-058419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118058419/doc4.xml","form_type":"4"}},{"id":3786286,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-19T22:00:13.000Z","date":"2018-10-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which the remaining unvested portion shall vest), beginning on 11/17/2018 and ending on 10/17/2019, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":6.03,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000904454-18-000680","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526119/000090445418000680/edgar.xml","form_type":"4"}},{"id":3837171,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-08-21T20:57:13.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":188,"price":18.21,"value":3423.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 16, 2015."}],"balance_after":97719,"source":{"system":"sec-edgar","filing":"0001209191-18-047765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118047765/doc4.xml","form_type":"4"}},{"id":3854948,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-08-02T21:53:18.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as a recognition award, vests as to 100% of the shares of Class A Common Stock on May 9, 2019."}],"balance_after":97907,"source":{"system":"sec-edgar","filing":"0001209191-18-045047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118045047/doc4.xml","form_type":"4"}},{"id":4040225,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option(Right to Buy)","published_at":"2018-02-22T23:02:03.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2018."}],"balance_after":60000,"derivative":{"exercise_price":14.55,"expiration_date":"2028-02-21","underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-18-012571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118012571/doc4.xml","form_type":"4"}},{"id":4040224,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-22T23:02:03.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":85907,"source":{"system":"sec-edgar","filing":"0001209191-18-012571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118012571/doc4.xml","form_type":"4"}},{"id":4040223,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-22T23:02:03.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":1920,"price":14.66,"value":28147.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $14.92, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":55907,"source":{"system":"sec-edgar","filing":"0001209191-18-012571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118012571/doc4.xml","form_type":"4"}},{"id":4040222,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-22T23:02:03.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":1298,"price":14.66,"value":19028.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $14.92, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":57827,"source":{"system":"sec-edgar","filing":"0001209191-18-012571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118012571/doc4.xml","form_type":"4"}},{"id":4040221,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-22T23:02:03.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":376,"price":14.66,"value":5512.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $14.92, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":59125,"source":{"system":"sec-edgar","filing":"0001209191-18-012571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118012571/doc4.xml","form_type":"4"}},{"id":4111671,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-04T01:06:59.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, granted as a promotion award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of November 27, 2017."}],"balance_after":15000,"derivative":{"exercise_price":15.27,"expiration_date":"2028-01-02","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-001574","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118001574/doc4.xml","form_type":"4"}},{"id":4111670,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-01-04T01:06:59.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as a promotion award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":59501,"source":{"system":"sec-edgar","filing":"0001209191-18-001574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118001574/doc4.xml","form_type":"4"}},{"id":4163587,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO and CAO"}}],"security":"Class A Common Stock","published_at":"2017-11-14T21:10:02.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":864,"price":15.2,"value":13132.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.32, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":52001,"source":{"system":"sec-edgar","filing":"0001209191-17-060593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117060593/doc4.xml","form_type":"4"}},{"id":4227490,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2017-08-22T20:07:10.000Z","date":"2017-08-18","kind":"sale","acquired":false,"shares":207,"price":14.34,"value":2968.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 16, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.20 to $14.47, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":52865,"source":{"system":"sec-edgar","filing":"0001209191-17-049809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117049809/doc4.xml","form_type":"4"}},{"id":4417610,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-28T21:03:26.000Z","date":"2017-02-27","kind":"grant","acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":53072,"source":{"system":"sec-edgar","filing":"0001209191-17-015221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117015221/doc4.xml","form_type":"4"}},{"id":4417609,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-28T21:03:26.000Z","date":"2017-02-24","kind":"sale","acquired":false,"shares":2962,"price":16.53,"value":48961.86,"ownership":{"direct":true},"balance_after":26822,"source":{"system":"sec-edgar","filing":"0001209191-17-015221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117015221/doc4.xml","form_type":"4"}},{"id":4424520,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-24T21:34:31.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":1431,"price":16.94,"value":24241.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":29784,"source":{"system":"sec-edgar","filing":"0001209191-17-014354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117014354/doc4.xml","form_type":"4"}},{"id":4424519,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-24T21:34:31.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":408,"price":16.94,"value":6911.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":31215,"source":{"system":"sec-edgar","filing":"0001209191-17-014354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117014354/doc4.xml","form_type":"4"}},{"id":4515322,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2016-12-20T22:40:31.000Z","date":"2016-12-16","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":31623,"source":{"system":"sec-edgar","filing":"0001209191-16-156155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919116156155/doc4.xml","form_type":"4"}}]}